| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.27 | 6e-15 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.23 | 9e-13 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-12 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.34 | 1e-11 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-11 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.3 | 1e-10 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.34 | 5e-10 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.28 | 6e-09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |